Recent Quotes

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		-0.390		-0.380		0.0100
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
GLMD	Galmed Pharmaceuticals	3.00	0.04	1.35%		74.2M

Galmed Pharmaceuticals Frequently Asked Questions

How do I buy Galmed Pharmaceuticals (GLMD) stock?

You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.

View our list of the best stock brokerages.

Who are Galmed Pharmaceuticals's (GLMD) competitors?

There are no as such competitors for Galmed Pharmaceuticals.

What is the target price for Galmed Pharmaceuticals (GLMD) stock?

The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Canaccord Genuity on May 17, 2021. The analyst firm set a price target for 21.00 expecting GLMD to rise to within 12 months (a possible 609.46% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Galmed Pharmaceuticals (GLMD)?

The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $2.96 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Does Galmed Pharmaceuticals (GLMD) pay a dividend?

There are no upcoming dividends for Galmed Pharmaceuticals.

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

Galmed Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is Galmed Pharmaceuticals (GLMD) going to split?

There is no upcoming split for Galmed Pharmaceuticals.

What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

Galmed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.